PREVENT Subgroup Analysis: Identifying Enhanced Benefit of Preventive PCI in Patients with Prior Non-Target Vessel Revascularization July 09, 2025 39 0 Read More
ENAVO-TAVR Trial: SGLT2 Inhibitor Therapy for HFpEF in Post-TAVR Patients July 09, 2025 11 0 Read More
Potassium-Competitive Acid Blocker Versus Proton-Pump Inhibitor in Patients Receiving Antithrombotic Therapy Who Are at High Risk for Gastrointestinal Bleeding: Rationale and Design of PROTECT-HBR Trial July 09, 2025 10 0 Read More
Revascularization Strategy for Multivessel Coronary Artery Disease Patients with Diabetes Mellitus PCI Versus CABG July 09, 2025 8 0 Read More
Introduction of FATE-MAIN Trial: A Randomized Comparison of FFR-Guided Versus Angiography-Guided PCI in Patients with Significant Left Main Coronary Artery Disease July 09, 2025 11 0 Read More
